What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly disclose that Bristol-Myers Squibb Company has posted an investor presentation on its website, and to provide this presentation as an exhibit to the filing.

Where can I find the investor presentation mentioned in the filing?

The investor presentation dated January 10, 2022, is available on Bristol-Myers Squibb's investor relations website at www.bms.com/investors/events-and-presentations.html. It is also attached as Exhibit 99.1 to this 8-K filing.

Does this filing contain new financial results for BMY?

No, this 8-K filing does not contain new financial results. It is a disclosure of an investor presentation, which may contain forward-looking information or strategic updates, but it is not a formal earnings release.

What is the significance of the information not being 'filed' for Section 18 purposes?

This means that the company is not subject to the same liabilities under Section 18 of the Securities Exchange Act of 1934 for the information in this presentation as it would be for information formally filed with the SEC, such as in a 10-K or 10-Q. However, it's still important information for investors to consider.

BRISTOL MYERS SQUIBB CO 8-K: Regulation FD

Summary

Bristol-Myers Squibb Company (BMY) has filed an 8-K report on January 10, 2022, primarily to disclose the posting of an investor presentation on their website. This presentation, dated January 10, 2022, is attached as Exhibit 99.1 to the filing. Investors are directed to the company's investor relations website for access to this presentation. While this filing does not contain new financial results or material business updates beyond the presentation, it serves as a formal notification to the market about updated investor materials. Investors should review the attached presentation for the latest information and perspectives directly from the company, which may cover strategic initiatives, pipeline updates, or financial outlooks.

Key Highlights

1BMY filed an 8-K report on January 10, 2022.
2The primary purpose of the filing is to disclose an investor presentation.
3An investor presentation dated January 10, 2022, is attached as Exhibit 99.1.
4The investor presentation is available on the BMY investor relations website (www.bms.com/investors/events-and-presentations.html).
5This filing does not constitute a financial results release.
6Information provided is not deemed 'filed' for Section 18 liability purposes.
7The filing includes an Inline XBRL cover page.

BRISTOL MYERS SQUIBB CO 8-K Report, Regulation FD Disclosure (Jan 10, 2022)

Summary

Key Highlights

Frequently Asked Questions